Article
Precision medicine for the discovery of treatable mechanisms in severe asthma
13 Mar 2019
Abstract excerpt
Although the complex disease of asthma has been defined as being heterogeneous, the extent of its endophenotypes remains unclear. The pharmacological approach to initiating treatment has, until recently, been based on disease control and severity. The introduction of antibody therapies targeting the Type 2 inflammation pathway for patients with severe asthma has resulted in the recognition of an allergic and an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.